Eli Lilly stock plunges toward its worst day since 2000 on disappointing earnings and Zepbound sales

Topline Drugmaker Eli Lilly's stock price plunged Wednesday morning after the company reported worse-than-expected third-quarter results, particularly in its weight-loss drug division, in a rare misstep for the Wall Street darling. Eli Lilly shares are on track for their worst…